A
MRNA icon

AlphaQuest’s Moderna MRNA Stock Holding History

AlphaQuest’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-841
Closed -$24.8K – 1270
2025
Q4 		$24.8K Sell
841
-35,300
-98% -$959K ﹤0.01% 2074
2025
Q3 		$934K Buy
36,141
+13,096
+57% +$365K 0.06% 460
2025
Q2 		$636K Buy
23,045
+18,460
+403% +$486K 0.06% 490
2025
Q1 		$130K Buy
4,585
+2,572
+128% +$91.3K 0.01% 1189
2024
Q4 		$83.7K Sell
2,013
-2,554
-56% -$122K 0.01% 1148
2024
Q3 		$305K Buy
4,567
+3,223
+240% +$296K 0.03% 893
2024
Q2 		$160K Buy
1,344
+1,333
+12,118% +$169K 0.02% 819
2024
Q1 		$1.17K Buy
+11
New +$1.11K ﹤0.01% 1325

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaQuest's MRNA Position: Q1 2026 in Review

AlphaQuest sold out of Moderna (MRNA) in Q1 2026, closing a stake of 841 shares — an estimated $24.8K sold.

AlphaQuest first reported a position in MRNA in Q1 2024 and held it in 8 quarters. The position peaked at $934K in Q3 2025. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • AlphaQuest reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 841 Moderna shares in Q1 2026, an estimated $24.8K.
  • AlphaQuest first reported a position in Moderna in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Moderna position peaked at $934K in Q3 2025.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.